These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1111 related articles for article (PubMed ID: 24484236)

  • 41. Immunological markers of anti-tumor dendritic cells vaccine efficiency in patients with non-small cell lung cancer.
    Skachkova OV; Khranovska NM; Gorbach OI; Svergun NM; Sydor RI; Nikulina VV
    Exp Oncol; 2013 Jun; 35(2):109-13. PubMed ID: 23828386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
    Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC
    J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prognostic value of intraepithelial and stromal CD3-, CD117- and CD138-positive cells in non-small cell lung carcinoma.
    Al-Shibli K; Al-Saad S; Andersen S; Donnem T; Bremnes RM; Busund LT
    APMIS; 2010 May; 118(5):371-82. PubMed ID: 20477813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of spontaneous tumor-specific CD4 T-cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy response.
    Godet Y; Fabre E; Dosset M; Lamuraglia M; Levionnois E; Ravel P; Benhamouda N; Cazes A; Le Pimpec-Barthes F; Gaugler B; Langlade-Demoyen P; Pivot X; Saas P; Maillère B; Tartour E; Borg C; Adotévi O
    Clin Cancer Res; 2012 May; 18(10):2943-53. PubMed ID: 22407833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer.
    Ho CC; Liao WY; Wang CY; Lu YH; Huang HY; Chen HY; Chan WK; Chen HW; Yang PC
    Am J Respir Crit Care Med; 2008 Apr; 177(7):763-70. PubMed ID: 18096709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The large scale generation of dendritic cells for the immunization of patients with non-small cell lung cancer (NSCLC).
    Yannelli JR; Sturgill J; Foody T; Hirschowitz E
    Lung Cancer; 2005 Mar; 47(3):337-50. PubMed ID: 15713517
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of circulating anti-p53 antibodies in patients with advanced non-small cell lung cancer and their correlation to clinical parameters and survival.
    Bergqvist M; Brattström D; Larsson A; Hesselius P; Brodin O; Wagenius G
    BMC Cancer; 2004 Sep; 4():66. PubMed ID: 15367333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
    Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dendritic cells in peripheral blood of patients with breast and lung cancer--a pilot study.
    Wojas K; Tabarkiewicz J; Jankiewicz M; Roliński J
    Folia Histochem Cytobiol; 2004; 42(1):45-8. PubMed ID: 15046400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reviving up dendritic cells can run cancer immune wheel in non-small cell lung cancer: a prospective two-arm study.
    Zahran AM; Hetta HF; Mansour S; Saad ES; Rayan A
    Cancer Immunol Immunother; 2021 Mar; 70(3):733-742. PubMed ID: 32918587
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Immunomorphology of lymph nodes and prognosis in lung cancer].
    Di Giorgio A; Sammartino P; Canavese A; Arnone P; Sibio S; Accarpio F; Al Mansour M
    Minerva Chir; 2001 Apr; 56(2):153-9. PubMed ID: 11353348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity.
    Germain C; Gnjatic S; Dieu-Nosjean MC
    Front Immunol; 2015; 6():67. PubMed ID: 25755654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. WT1 IgG antibody for early detection of nonsmall cell lung cancer and as its prognostic factor.
    Oji Y; Kitamura Y; Kamino E; Kitano A; Sawabata N; Inoue M; Mori M; Nakatsuka S; Sakaguchi N; Miyazaki K; Nakamura M; Fukuda I; Nakamura J; Tatsumi N; Takakuwa T; Nishida S; Shirakata T; Hosen N; Tsuboi A; Nezu R; Maeda H; Oka Y; Kawase I; Aozasa K; Okumura M; Miyoshi S; Sugiyama H
    Int J Cancer; 2009 Jul; 125(2):381-7. PubMed ID: 19384943
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tertiary Lymphoid Structures: Autoimmunity Goes Local.
    Pipi E; Nayar S; Gardner DH; Colafrancesco S; Smith C; Barone F
    Front Immunol; 2018; 9():1952. PubMed ID: 30258435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study.
    Fukuhara M; Muto S; Inomata S; Yamaguchi H; Mine H; Takagi H; Ozaki Y; Watanabe M; Inoue T; Yamaura T; Okabe N; Matsumura Y; Hasegawa T; Osugi J; Hoshino M; Higuchi M; Shio Y; Suzuki H
    Cancer Immunol Immunother; 2022 May; 71(5):1129-1137. PubMed ID: 34596720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of Tools for the Selective Visualization and Quantification of TLS-Immune Cells on Tissue Sections.
    Klein C; Devi-Marulkar P; Dieu-Nosjean MC; Germain C
    Methods Mol Biol; 2018; 1845():47-69. PubMed ID: 30141007
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immune infiltration in human cancer: prognostic significance and disease control.
    Fridman WH; Galon J; Dieu-Nosjean MC; Cremer I; Fisson S; Damotte D; Pagès F; Tartour E; Sautès-Fridman C
    Curr Top Microbiol Immunol; 2011; 344():1-24. PubMed ID: 20512556
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulatory T cells infiltrate the tumor-induced tertiary lymphoïd structures and are associated with poor clinical outcome in NSCLC.
    Devi-Marulkar P; Fastenackels S; Karapentiantz P; Goc J; Germain C; Kaplon H; Knockaert S; Olive D; Panouillot M; Validire P; Damotte D; Alifano M; Murris J; Katsahian S; Lawand M; Dieu-Nosjean MC
    Commun Biol; 2022 Dec; 5(1):1416. PubMed ID: 36566320
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tertiary Lymphoid Structures, Immune Response, and Prognostic Relevance in Non-Small Cell Lung Cancer.
    Giatromanolaki A; Chatzipantelis P; Contrafouris CA; Koukourakis MI
    Cancer Invest; 2023 Jan; 41(1):48-57. PubMed ID: 36239379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Mature Tertiary Lymphoid Structure with a Ki-67-Positive Proliferating Germinal Center Is Associated with a Good Prognosis and High Intratumoral Immune Cell Infiltration in Advanced Colorectal Cancer.
    Mori N; Dorjkhorloo G; Shiraishi T; Erkhem-Ochir B; Okami H; Yamaguchi A; Shioi I; Komine C; Endo M; Seki T; Hosoi N; Nakazawa N; Shibasaki Y; Okada T; Osone K; Sano A; Sakai M; Sohda M; Yokobori T; Shirabe K; Saeki H
    Cancers (Basel); 2024 Jul; 16(15):. PubMed ID: 39123412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.